Y90 Microspheres Education and Support Offers Straight Talk About Treating Liver Tumors Webinar

Denver, CO, January 20, 2008 --(PR.com)-- Discovering that you or a loved one has liver involvement from cancer is frightening. The prognosis can be very scary and options can be few. As life seems to spin out of control, Yttrium 90 Microspheres Education and Support provides support and hope to those affected by liver tumors so that no one faces their journey alone. They are offering the following webinar to increase the awareness of Yttrium 90 Radioembolization. This procedure for advanced liver tumors utilizes millions of tiny radioactive beads to deliver targeted, internal radiation therapy to the tumor(s). Patients who are not candidates for liver resection or other targeted liver treatment choices will sometimes qualify for this novel treatment.

Date & Time:
01/31/08 2:00 pm (US/Eastern)
Duration: 60 minutes

Speaker Information:
Dr. Charlie Nutting is a fellowship trained, board certified interventional radiologist specializing in Interventional Oncology procedures. He was the first physician in the United States to perform hepatic radioembolization with SIR-Spheres in March, 2002. Since then he has performed over 300 radioembolizations utilizing both Therasphere and SIR-spheres products. He has been co-author on several important clinical papers regarding the use of radioactive microspheres. "Taking advantage of the tumor's own increased blood supply is what is so elegant about the delivery of radioactive microspheres. We can target very high radiation doses into the tumors and sill relatively spare the normal liver tissue." His practice also includes chemoembolization as well as image guided radiofrequency ablation of liver, kidney, and lung tumors.

###